# Growth Hormone and Brain Functioning After Traumatic Brain Injury

> **NCT01699308** · PHASE1 · COMPLETED · sponsor: **Joe Springer** · enrollment: 15 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Genotropin

## Key facts

- **NCT ID:** NCT01699308
- **Lead sponsor:** Joe Springer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-01
- **Primary completion:** 2014-04-01
- **Final completion:** 2014-04-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01699308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01699308, "Growth Hormone and Brain Functioning After Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01699308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*